Page last updated: 2024-08-23

tetradecanoylphorbol acetate and carboplatin

tetradecanoylphorbol acetate has been researched along with carboplatin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eastman, A; Hom, DK; Howell, SB; Isonishi, S1
Arteaga, CL; Ohmori, T1
Howell, SB; Isonishi, S; Ohkawa, K; Tanaka, T1

Other Studies

3 other study(ies) available for tetradecanoylphorbol acetate and carboplatin

ArticleYear
Enhancement of sensitivity to platinum(II)-containing drugs by 12-O-tetradecanoyl-phorbol-13-acetate in a human ovarian carcinoma cell line.
    British journal of cancer, 1994, Volume: 69, Issue:2

    Topics: Carboplatin; Cisplatin; Cystadenocarcinoma, Serous; DNA, Neoplasm; Drug Synergism; Enzyme Activation; Female; Glutathione; Glutathione Transferase; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Protein Kinase C; Pyrazoles; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1994
Protein kinase C epsilon translocation and phosphorylation by cis-diamminedichloroplatinum(II) (CDDP): potential role in CDDP-mediated cytotoxicity.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1998, Volume: 9, Issue:4

    Topics: Antineoplastic Agents; Biological Transport; Breast Neoplasms; Carboplatin; Carcinoma; Cisplatin; Cytosol; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; Humans; Isoenzymes; Microcystins; Nuclear Envelope; Oligonucleotides, Antisense; Peptides, Cyclic; Phosphoprotein Phosphatases; Phosphorylation; Protein Kinase C; Protein Kinase C-epsilon; Protein Phosphatase 2; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1998
Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells.
    British journal of cancer, 2000, Volume: 82, Issue:1

    Topics: Antineoplastic Agents; Carboplatin; Carcinogens; Cisplatin; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Female; Glutathione; Humans; Isoenzymes; Ovarian Neoplasms; Protein Kinase C; Protein Kinase C-alpha; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tumor Stem Cell Assay

2000